Breaking News
Sort by:
Top Post
Almirall Appoints Mercedes Diz as VP, Corporate Strategy
Almirall, a global biopharmaceutical company focused on skin health, today announced that Mercedes Diz will […]
Mirati Therapeutics Appoints Laurie Stelzer as Chief Financial Officer
Mirati Therapeutics, Inc. (NASDAQ: MRTX), a clinical-stage targeted oncology company, today announced the appointment of Laurie Stelzer as […]
Vytal Announces the Appointment of Prasanna Parthasarathy as Chief Executive Officer
Vytal, a pharmacy service and healthcare technology company, today announced the appointment of Prasanna Parthasarathy as chief […]
Kineticos Life Sciences Announces Tom Pitler as President and Chief Operating Officer
Kineticos Life Sciences announced today that Thomas A. Pitler, Ph.D. has joined as President and Chief Operating […]
ADA Names Charles D. Henderson as New Chief Executive Officer
The American Diabetes Association® (ADA), the nation’s leading voluntary health organization fighting to bend the curve […]
BICO Group Adds Senior Ir Manager to Its Executive Management
Åsa Hillsten has been appointed SVP and Head of IR at BICO and will be […]
Johnson & Johnson Appoints Thibaut Mongon as CEO Designate of Planned New Consumer Health Company
Johnson & Johnson (the “Company”) (NYSE: JNJ) today announced the appointment of Thibaut Mongon as […]
INOVIO Announces the Appointment of Jacqueline Shea, Ph.D., as Chief Executive Officer
INOVIO (NASDAQ: INO), a biotechnology company focused on developing and commercializing DNA medicines to help protect […]
Sphere Fluidics Strengthens Commercial Team With Three New Senior Hires
Sphere Fluidics, a company developing single cell analysis systems underpinned by its patented picodroplet technology, […]
Bausch Health Announces Thomas J. Appio As Chief Executive Officer
Bausch Health Companies Inc. (NYSE/TSX: BHC) (Bausch Health) today announced its full leadership team and […]
Immunicum AB: Immunicum Appoints Leopold Bertea as Chief Technology Officer
Immunicum AB (“Immunicum” publ; IMMU.ST), a biopharmaceutical company focused on therapies addressing tumor recurrence and hard-to-treat […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more